William D. Turner's most recent trade in Vera Therapeutics Inc - Ordinary Shares - Class A was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 25,000 | 47,500 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 10,000 | 245,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 50.08 per share. | 15 Dec 2025 | 10,000 | 22,500 | - | 50.1 | 500,767 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.53 per share. | 15 Dec 2025 | 10,000 | 32,500 | - | 15.5 | 155,300 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.53 per share. | 08 Dec 2025 | 10,000 | 32,500 | - | 15.5 | 155,300 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 10,000 | 255,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 45.31 per share. | 08 Dec 2025 | 10,000 | 22,500 | - | 45.3 | 453,053 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 265,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 03 Dec 2025 | 10,000 | 22,500 | - | 40 | 400,000 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.53 per share. | 03 Dec 2025 | 10,000 | 32,500 | - | 15.5 | 155,300 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | William D. Turner | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 22,500 | 22,500 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | D. Turner William | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 275,000 | 275,000 | - | - | Stock Option (right to buy) |